Trial Outcomes & Findings for Tear Lipid Layer Thickness With Emollient Eye Drops (NCT NCT03380624)
NCT ID: NCT03380624
Last Updated: 2021-02-03
Results Overview
Change in tear lipid layer thickness
Recruitment status
COMPLETED
Study phase
PHASE4
Target enrollment
21 participants
Primary outcome timeframe
15 minutes
Results posted on
2021-02-03
Participant Flow
2 participants were found to be ineligible after completing the baseline visit.
Participant milestones
| Measure |
Refresh Optive Then Refresh Optive MEGA 3
The subjects are randomly assigned to one drop of Refresh Optive or Refresh Optive MEGA followed by measurement of lipid layer thickness at 15 minutes and 1 hour After which there is a washout period before Visit 2 - in which the measurements were repeated with the other eye drop.
|
Refresh Optive MEGA 3 Then Refresh Optive
The subjects are randomly assigned to one drop of Refresh Optive or Refresh Optive MEGA followed by measurement of lipid layer thickness at 15 minutes and 1 hour After which there is a washout period before Visit 2 - in which the measurements were repeated with the other eye drop.
|
|---|---|---|
|
Overall Study
STARTED
|
10
|
9
|
|
Overall Study
COMPLETED
|
10
|
9
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Refresh Optive and Refresh Optive MEGA
n=19 Participants
The subjects are randomly assigned to Refresh Optive or Refresh Optive MEGA (Omega 3) with measurements of lipid layer thickness following at 15 minutes and 1 hour.
After which there is a washout period before proceeding to the second eye drop at visit 2.
Refresh Optive: Lubricate and hydrating relief of eye dryness investigational lubricant eye drop is based on carboxymethylcellulose
Refresh Optimum OMEGA 3: Lubricate and hydrating relief of eye dryness investigational lubricant eye drop is based on carboxymethylcellulose and with flaxseed oil and trehalose
\*All subjects completed both arms in this crossover study
|
|---|---|
|
Age, Customized
Age 30 to 65
|
19 Participants
n=19 Participants
|
|
Sex: Female, Male
Female
|
13 Participants
n=19 Participants
|
|
Sex: Female, Male
Male
|
6 Participants
n=19 Participants
|
|
Lipid layer thickness
|
40.9 nm
STANDARD_DEVIATION 10.1 • n=19 Participants
|
PRIMARY outcome
Timeframe: 15 minutesChange in tear lipid layer thickness
Outcome measures
| Measure |
Refresh Optive
n=19 Participants
Participants were first randomized to have 1 drop of Refresh Optive instilled in each eye with measurements of lipid layer thickness following at 15 minutes and 1 hour.
After which there is a washout period before proceeding to a second visit in which Refresh Optive MEGA-3 was utilized and the measurements were repeated.
Refresh Optive: Lubricate and hydrating relief of eye dryness investigational lubricant eye drop is based on carboxymethylcellulose
Refresh Optimum OMEGA 3: Lubricate and hydrating relief of eye dryness investigational lubricant eye drop is based on carboxymethylcellulose and with flaxseed oil and trehalose
\*All subjects completed both arms in this crossover study
|
Refresh Optive MEGA-3
n=19 Participants
Participants were first randomized to have 1 drop of Refresh Optive MEGA-3 instilled in each eye with measurements of lipid layer thickness following at 15 minutes and 1 hour.
After which there is a washout period before proceeding to a second visit in which Refresh Optive was utilized and the measurements were repeated.
|
|---|---|---|
|
Change in Tear Lipid Layer Thickness
|
4.8 nm
Standard Deviation 14.9
|
8.8 nm
Standard Deviation 11.5
|
Adverse Events
Refresh Optive
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Refresh Optive MEGA
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Jennifer Fogt
The Ohio State University College of Optometry
Phone: 614-292-2020
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place